Clinical trials
Recruiting Phase 1/2 trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
95 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 9 |
| 2023 | 16 |
| 2024 | 18 |
| 2025 | 25 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 95 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 9 |
| AstraZeneca | 5 |
| Princess Maxima Center for Pediatric Oncology | 5 |
| GlaxoSmithKline | 4 |
| University Medical Center Groningen | 4 |
| Bristol-Myers Squibb | 3 |
| ModernaTX, Inc. | 3 |
| Pierre Fabre Medicament | 3 |
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 3 |
| The Netherlands Cancer Institute | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 13 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Colorectal Neoplasms | 8 |
| Ovarian Neoplasms | 8 |
| Endometrial Neoplasms | 7 |
| Leukemia | 5 |
| Melanoma | 5 |
| Neoplasm Metastasis | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Recurrence | 5 |
Trials
Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.